Clinical trial
Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for…
NCT00175851 · UCB Pharma, Industry · Withdrawn
Key facts
| NCT number | NCT00175851 |
|---|---|
| Title | Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy |
| Official title | An Open-label, Multicenter, Follow-up Trial to Evaluate the Long-term Safety and Efficacy of Seletracetam Used as Adjunctive Treatment Using a Flexible Dosing Scheme of 4 to 80 mg b.i.d. in Subjects Aged 16 Years or Older Suffering From Epilepsy |
| Lead sponsor | UCB Pharma, Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Seletracetam (ucb 44212) |
| Enrollment | 0 |
| Start date | May 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | May 28, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: